LFB, 3.348% 31dec2027, EUR (FIGI BBG011C6QPL2, FR00140039V5)
国内債券, Subordinated Unsecured
国内債券, Subordinated Unsecured
|
Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products. The LFB Group is now one of the leading European players in biopharmaceutical, its products are aimed at ...
Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products. The LFB Group is now one of the leading European players in biopharmaceutical, its products are aimed at health professionals, mainly hospital based, these are medicinal products derived from living organisms in three major fields of therapy immunology, haemostasis and intensive care. LFB is a public company and the Group is growing in a competitive sector, with medicinal products sold in nearly 60 countries.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
175 910
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡